About Huawei Health

       Established in 1992, Huawei Pharmaceutical Group is a joint venture affiliated to National Health Commission of the People’s Republic of China (the original Ministry of Health P. R. China). In the initial period of founding, it only guaranteed the pharmaceutical security of the Leading Cadre and various ministries and commissions. After over 2 decades of development, it has engaged in 4 major fields, including medicine sales, medical consulting, pharmaceutical consulting and new product technology development to urge the health undertaking of the Chinese people, medical and healthcare services and international exchanges, so as to strive for the great goal of Healthy China.

1992

Founded in 1992

30

Over 30 years of growth

3

Three core business segments
Company Mission
  • Become an integrator, innovator and sharer in the field of Chinese Massive Health and serve our customers in health wholeheartedly

Company Strengths

Strategic Platform Advantage

Huawei Health actively participates in Boao Lecheng International Medical Tourism Pilot Zone cooperation and project delivery. Lecheng offers medical special-zone policies, real-world research settings, and channels for importing innovative medicines and devices—serving as a key platform for global resources entering China and for innovation landing.
Mission

International Cooperation Advantage

We maintain strategic cooperation with DIA, leveraging its network across 80+ countries and regions to connect regulators, industry, research, and clinical experts. Cooperation includes product selection and import, international conferences, talent training, and overseas liaison offices—not just branding.
Positioning

Resource Integration & Execution

Unlike traditional resource-brokerage services, Huawei Health delivers full-chain, closed-loop execution capabilities. Built on years of industry experience, we operate a standardized project management system and excel at multi-party coordination, cross-border resource integration, and commercialization. With deep expertise in international business cooperation and conference organization, we bring proven cross-border project execution. Leveraging Boao Lecheng's policy advantages, we connect policy platforms, international resources, and local operations—focusing on real-world research, clinical engagement, and market access. Results-driven, we go beyond superficial introductions and use professional execution to empower two-way industrialization of innovative medicines and devices between China and global markets.
Positioning

Core Team Advantage

Our team combines industry, BD, execution, and international cooperation experience. Core members from leading Chinese companies bring strategic, operational, and project delivery strengths—a hybrid team that understands industry, partnership, execution, and landing.
Positioning

Mobile Site

WeChat Site

Address: 28th Floor, Nanyin Building, No. 2 East Third Ring North Road, Chaoyang District, Beijing
Phone: 010-61006202
Personnel recruitment consultation: li-ll@moh-hw.com
Investment and BD cooperation: BD@moh-hw.com
Medical sales consultation: zhang-b@moh-hw.com

Huawei Health Management Group. All Rights Reserved (C) 2021  Powered by PharmNet.com.cn Toocle NetSun Copyright Notice 京ICP备2026038759
Online Drug and Medical Device Information Service Filing: Non-commercial -(京) Online Drug and Device Information Record No. (2026) 00146